Spenser Lin No Comments

Healthcare News, Deals, and Investments Update September 14th, 2026

LECO_Weekly-Healthcare-News_9-14-2026Download

Healthcare Weekly News and Deals –Sept 14th, 2026

  1. Addus HomeCare (NASD: ADUS) to Acquire Advent International–Backed AccentCare’s Personal Care Division for Approximately $275 Million Advent International’s AccentCare is selling only the non-New York personal-care book; hospice and skilled home health stay with the seller. Addus, a scaled non-franchise home-care operator listed on Nasdaq, is paying about $275 million after customary adjustments and funding the check with revolver and cash. The assets serve roughly 13,700 patients a day across 10 states and should add about $280 million of annualized personal-care revenue, a 19% lift to Addus’s base. Density is heaviest in Texas, Illinois, California and Arizona, with additional volume in Colorado, Georgia, Minnesota, Pennsylvania, Tennessee and Washington. The purchase extends Addus’s Medicaid-heavy personal-care footprint rather than buying hospice or Medicare home health.  (Link)
  2. Axogen (NASD: AXGN) to Acquire BioCircuit Technologies for $200 Million in Cash Axogen is paying $200 million cash for BioCircuit, with $1 million held back for the post-close true-up, and is funding the check with a concurrent $208.7 million common-stock offering. The prize is NerveTape, the first FDA-cleared sutureless device for peripheral nerve repair, plus ConformaWrap. BioCircuit did about $11 million of revenue in 2025 and is running at roughly $24 million on more than 14,000 implants across 400-plus hospital and ASC accounts. Convertible notes convert and an unrelated electronics R&D unit is spun out before closing. Management expects year-one accretion to growth, adjusted EBITDA margin and adjusted EPS while remaining free-cash-flow positive.  (Link)
  3. COSCIENS Biopharma (TSX: CSCI) Acquires Nualtis from AtaiBeckley (NASD: ATAI) for $15 Million Plus Earnouts COSCIENS is buying Montreal oral-thin-film CDMO Nualtis, formerly IntelGenx, from AtaiBeckley for $15 million plus four earnouts equal to 10% of adjusted EBITDA in 2027–2030. Nine million dollars was paid at close; $6 million is deferred six months. The plant is FDA- and Health Canada-inspected and runs VersaFilm for human therapeutics and VetaFilm for veterinary use, with an existing pipeline and pharma partnerships. A concurrent first tranche of unsecured convertibles raised about $6 million toward a $20 million cap and funded the closing check. For a small TSX-listed ingredients company, the deal is a way to own a purpose-built film platform rather than build one.  (Link)
  4. Patient Square–Backed Hanger to Acquire AEA’s Numotion; Combined Company to Be Called Hanger Numotion Patient Square is putting two mobility platforms under one roof in a cash purchase. Hanger contributes 925 U.S. orthotic and prosthetic clinics; AEA Investors’ Numotion contributes more than 200 complex-rehab and mobility sites in the United States and Canada. Combined they will serve more than 1.5 million patients a year and keep both brands and clinical operations. Numotion CEO Mike Swinford, in the seat since 2014 after two decades at GE including GE Healthcare Services, will run the combined company as Hanger Numotion; Pete Stoy steps aside. The combination is PE-backed specialty-provider consolidation across complementary mobility verticals, not a single-clinic tuck-in.  (Link)
  5. Apple (NASD: AAPL) Acquires Berkeley Brain-Sensing Startup Sonera Apple has bought Sonera, a Berkeley company that builds chip-scale magnetic sensors to read neural and muscle activity without implants or skin-contact electrodes. Co-founders Nishita Deka and Dominic Labanowski started the firm in 2018 out of UC Berkeley; it later raised about $20 million, including an $11 million 2023 seed, and marketed an S1 biomagnetic chip for muscle sensing, prosthetics and wearables. Magnetic readout is meant to avoid the skull-dampening that limits electrical EEG. Apple has not said what the team will work on. Outside write-ups point at Watch-class neuromuscular monitoring and hands-free accessibility; those uses are inferred, not confirmed. (Link)
  6. Labcorp (NYSE: LH) Acquires Great Point Partners’ MLM Medical Labs Great Point Partners is exiting MLM Medical Labs, the central- and specialty-lab it built in the United States, Germany and South Africa. Labcorp is folding the network in so it owns laboratories on four continents — North America, Europe, Asia and Africa — including the first CAP-accredited central lab on the African continent. MLM adds biomarker and specialty capacity for multinational trial work that Labcorp previously covered through a mix of owned sites and partners. The industrial logic is one operator, one scientific and regulatory stack, on global protocols rather than a patchwork of affiliate labs.  (Link)
  7. General Catalyst– and CVS Health Ventures–Backed H1 Acquires Defacto Health to Add Provider-Network Intelligence H1, the physician-data platform backed by General Catalyst and more recently CVS Health Ventures, is buying Defacto Health, a specialist in payer-network and directory intelligence. Defacto maps which clinicians sit in which networks and which plans they accept — the data health plans use to test directory accuracy, isolate error clusters and benchmark access. It was already a data partner. Co-founders Ron Urwongse and Tarun J. Theogaraj, both formerly of CAQH, join H1 and will keep running the product inside the Doctor Graph rather than as a standalone brand. The buy sits against ongoing CMS and plan pressure on directory accuracy as provider and network data change continuously.  (Link)
  8. Eir Partners Acquires Accumulus Technologies, the Life-Sciences Regulatory Cloud Platform Eir Partners is buying Accumulus Technologies, a San Francisco regulatory-cloud platform that connects more than 75 agencies to life-sciences sponsors. The product is built for multi-agency review rather than point-to-point filings and already has live Veeva RIM connectivity. Accumulus was spun out of nonprofit Accumulus Synergy in 2025 so it could raise capital and sell commercially; CEO Francisco Nogueira stays. Eir, a healthcare software firm, is treating the asset as a category platform at the intersection of life sciences, technology and global regulation rather than a point tool for a single agency workflow.  (Link)
  9. 1315 Capital Buys Argonaut’s Life Sciences and Diagnostics Unit; Business Relaunches as Aluris Sciences 1315 Capital is buying only Argonaut’s life-sciences and diagnostics manufacturing unit and relaunching it as Aluris Sciences. Telegraph Hill Partners, New Vale Capital and management keep the Carlsbad aseptic fill-finish CDMO. Aluris runs formulation through commercial production for diagnostics, life-sciences and combination-product customers and will operate independently; staff and resources were already largely separate, so live programs do not move. Sale proceeds recycle into Argonaut’s fill-finish capacity. The structure is a clean carve-out rather than a whole-company sale of a dual-vertical CDMO.  (Link)
  10. SK Capital–Backed Precera Medical Acquires Additive Metal Services Precera Medical, the four-plant orthopedic and interventional OEM SK Capital carved out of LISI Medical in November 2025, is adding Additive Metal Services of Port Huron. The shop brings metal-injection molding and sinter-based additive manufacturing for precision components — robotic-surgery end effectors and distal interventional-catheter parts among the named uses. Precera already runs design, prototyping, precision machining, micro-feature work, automation and finished-device assembly across Minnesota and France. Customer programs and tooling stay. The add-on is process-capability adjacency on a new platform, not a new end-market.  (Link)
  11. Avesi Partners–Backed Danforth Health Acquires Ambit RD Avesi Partners’ Danforth Health is buying Ambit RD, a rare- and specialty-disease shop that sells commercial strategy, advanced analytics and AI-assisted patient identification into biopharma. CEO Rob Sederman and CCO Ned Kitfield stay. Ambit is the latest add onto a platform that has already rolled up Asymmetry Group, PharmaDirections, VPMR, Advyzom, Benchworks, Elite BioPharma Consulting and Argot Partners. The thesis is a single commercialization backbone from clinic through launch rather than another standalone consultancy sitting beside the last one. Rare-disease commercial work is one of the few remaining fee pools that still pays for specialist analytics.  (Link)
  12. RiverGlade Capital Makes Platform Investment in Senior Living Residences RiverGlade Capital is backing Senior Living Residences, the Braintree operator of 24 independent living, assisted living and memory-support communities across New England and the broader Northeast. Founder Robert Larkin and CEO Tadd Clelland stay; the SLR name stays. The company has run service-enriched buildings for nearly four decades and includes the Compass Memory Support Neighborhoods line. RiverGlade is a healthcare PE firm that typically partners with founder-led lower-middle-market operators and funds people, operations and both organic and acquired growth. No price was printed. The check is meant to keep expanding the Northeast book without changing the operating identity. The transaction closed in July; this is the first public write-up.  (Link)
  13. Latticework Capital–Backed Beacon Behavioral Partners Acquires Albaron’s Prime Psychiatry Latticework Capital’s Beacon Behavioral Partners is buying Prime Psychiatry from Albaron Partners, which backed founder Dr. Efosa Airuehia in 2022. Prime is outpatient and interventional psychiatry — medication management plus TMS and Spravato — for children, adolescents and adults across Dallas–Fort Worth and Austin. The clinics join a national behavioral platform that has been adding partner practices across the Southeast and Midwest while leaving local brands intact. Local physicians stay. The sale is a sponsor-to-sponsor handoff of a regional interventional-psychiatry density play rather than a de novo clinic build.  (Link)
  14. Santé Ventures–Backed Jaguar LAA Acquires Johnson & Johnson (NYSE: JNJ) Laminar Program Assets Santé Ventures formed Jaguar LAA with members of the Laminar team to take Johnson & Johnson’s left-atrial-appendage program out of a strategic and finish development as an independent company. The asset is a catheter-based LAA-closure approach aimed at stroke-risk reduction in non-valvular atrial fibrillation and designed to leave minimal hardware in the left atrium. Key program assets and the originating engineers move together. The structure is a classic medtech carve-out plus NewCo financing rather than a license back to the seller.  (Link)
  15. InTandem-Backed Ivy Fertility Acquires Santa Barbara Fertility Center InTandem Capital’s Ivy Fertility is adding Santa Barbara Fertility Center, opened in 2008 by reproductive endocrinologist Rene Allen after a USC fellowship. Allen stays and continues to practice. The same announcement adds five other physicians across Ivy’s network and a build-out in male fertility. Local brand is retained. Ivy is already a multi-state IVF platform; Santa Barbara is a coastal California density add with an existing physician and lab book, not a 100%-owner partnership that leaves control unchanged.  (Link)
  16. LongueVue-Backed Summit / Pinnacle Acquires Dallas Research Institute LongueVue Capital’s Summit / Pinnacle site network is buying Dallas Research Institute, a single-site DFW unit opened in 2024 with the late hepatologist Dr. Stephen Harrison and focused on MASLD, MASH and obesity trials. Principal investigator Dr. Pedro Castillo Jr. stays. The buyer already runs 15 owned U.S. sites plus 110-plus partner sites in eight countries, with IRO, recruitment, medical-communications and early-phase CRO affiliates under the same roof. The add is metabolic-site density in a high-enrolling metro rather than a new therapeutic vertical.  (Link)
  17. VSS-Backed Olympus Cosmetic Group Acquires Gallaher Plastic Surgery & Med Spa VSS-backed Olympus Cosmetic Group is buying Gallaher Plastic Surgery & Med Spa, its first Tennessee practice and the entry into Knoxville. Dr. Tom Gallaher stays under a physician-led model and the local brand is being kept. Olympus is a surgeon-founded aesthetics platform assembling plastics and med-spa density market by market rather than a roll-up that rebrands every site on day one. The add-on is a local-brand-preserved clinic purchase into an unpenetrated MSA, not a new platform launch.  (Link)
  18. Frazier-Backed LUX Infusion Acquires Two Northeast Ambulatory Infusion Centers Frazier Healthcare’s LUX Infusion is buying two Northeast ambulatory infusion centers: South Jersey Pediatric and Adult Infusion Center in Cherry Hill, N.J., and Northeast Infusion Therapy in Latham, N.Y. The purchases are separate from the August Infuse IQ deal. LUX is a clinician-led home-plus-center platform after the BioMatrix rebrand. The two sites bring chair capacity and existing physician-referral books in two new Northeast MSAs, which is the density the platform needs if home infusion and AIC are going to sit on the same operating system.  (Link)
  19. Altas Partners and L Catterton Agree to Acquire Fullscript from HGGC Altas Partners and L Catterton are buying a majority stake in Fullscript from HGGC and Snapdragon Capital Partners. The Ottawa platform, founded in 2011, sells practitioners an integrated stack of diagnostics, treatment planning and dispensed supplements and already cites more than 135,000 clinicians, about 10 million patients a year and $1 billion-plus of revenue. HGGC and Snapdragon put $240 million in during 2021, later added Rupa Health for labs, and used a Leonard Green continuation vehicle in 2025. The new sponsors are taking majority control to fund further clinical-tool and North American expansion.  (Link)
  20. Revvity (NYSE: RVTY) to Acquire France’s Human Cell Design Revvity is buying Human Cell Design, a French specialist in human pancreatic beta-cell models. The flagship line is EndoC-βH5, sold with specialized media, reagents, preclinical services and the NatLine cell-line platform for diabetes, obesity and other metabolic work, including GLP-1 and GPCR programs. Revvity is treating the company as a reagents tuck-in that sits next to HTRF, AlphaLISA, ATPlite and high-content screening rather than a new instruments franchise. Human-relevant cell models have become a procurement item for metabolic and incretin discovery groups that want to reduce animal-only screening.  (Link)
  21. Novo Holdings Makes Minority Investment in China’s ForYou Medical; GL Capital Remains Majority Novo Holdings is taking a minority stake in ForYou Medical; GL Capital remains majority owner. The Huizhou company is a CDMO focused on advanced wound-care manufacturing for global device customers rather than a branded finished-goods play. Novo Holdings’ China head framed the check as the firm’s first China medtech ticket and part of a larger Asia ramp in both check size and local team. The industrial logic is specialized converting capacity plus China-to-global customer access, not a control deal or a domestic hospital chain.  (Link)
  22. Nvidia- and Health System–Backed Artisight Acquires TMG Global Artisight, the Nvidia- and health-system-backed smart-hospital vendor, is buying TMG Global, a healthcare infrastructure and site-readiness shop that runs large technology deployments. The team comes in-house so health systems have one accountable path from clinical-space and MDF/IDF surveys through hardware staging, install, validation, training and Day-1 support. Artisight’s platform uses computer vision and ambient sensing to run operating rooms and inpatient units; the bottleneck has been deployment, not the model. The purchase is operational capacity for enterprise rollouts, not a new clinical product.  (Link)
  23. Sanofi (NASD: SNY) and Braun Family–Owned Cheplapharm to Form Mature-Medicines Partnership Sanofi is moving a tail of 20 mature medicines and three plants to Cheplapharm, the German family-owned established-products company controlled by the Braun family, and taking a 26.4% equity stake in return. The plants are Csanyikvölgy in Hungary (about 400 employees), Jurong in Singapore (about 100) and Ploërmel in France (about 65), and they include manufacturing for Lovenox/Clexane. The two sides have collaborated since 2014. Commercial transfer is planned to start in early 2027, then the sites, subject to works-council consultation and regulatory approvals. Structure is a partnership and minority stake, not a signed control sale of Cheplapharm.  (Link)

Venture Deals and Other

  1. Forus Raises $150 Million Series C at a $3 Billion Valuation, Led by Bain Capital Ventures Bain Capital Ventures led a $150 million Series C in Forus at a $3 billion valuation, four months after a $160 million Series B. Every existing institution re-upped, including Thrive, General Catalyst, Accel, Redpoint, BoxGroup and Pear; cumulative capital now exceeds $300 million. Forus, formerly Tandem, builds an AI agent per prescription that sits between the physician, payer, pharmacy and manufacturer to clear access work and is free to doctors and patients. Coverage is all 50 states and about 85% of U.S. residential ZIP codes. Proceeds go to specialty expansion, more agents and commercial headcount.  (Link)
  2. BrainChild Bio Closes $116 Million Series A BrainChild Bio raised $116 million in a Series A led by a family fund and foundation aligned with the pediatric-oncology mission; Seattle Children’s, the original investor, and WRF Capital joined. Proceeds fund ILLUMINATE, the Phase 2 pivotal trial of BCB-276, a B7-H3 CAR-T, in diffuse intrinsic pontine glioma, and push triple-target construct BCB-214 toward first-in-human glioblastoma work. The platform is licensed from Seattle Children’s. Steven Brugger is CEO. DIPG remains a category with almost no approved options, which is why a mission-aligned family check can lead a round of this size.  (Link)
  3. TwoStep Therapeutics Raises Oversubscribed $62.5 Million Series A; FDA Clears TS-104 IND Insight Partners and Medical Excellence Capital led an oversubscribed $62.5 million Series A in TwoStep Therapeutics; Pfizer Ventures and Merck KGaA’s M Ventures co-led, with NFX, 2048 Ventures and Stanford joining. Cumulative capital is $71.2 million. The company’s peptide-drug conjugate binds five tumor-associated integrins rather than a single antigen, a design aimed at tumors that lack a clean one-target profile. FDA has cleared the TS-104 IND; Phase 1 enrollment is expected later this year. Proceeds also fund a radioligand program and next-generation peptide conjugates.  (Link)
  4. Kura Oncology (NASD: KURA) Launches Caspian Therapeutics with $50 Million Series A Led by BVF; Eli Lilly (NYSE: LLY) Participates Kura Oncology launched Caspian Therapeutics with a $50 million Series A led by BVF Partners. Kura contributed menin-inhibitor IP including KO-7246, invested $4.3 million and keeps about 49%. Eli Lilly and the T1D Fund joined, alongside Invus, Montanova and Kura management. Proceeds take KO-7246 into Type 1 and Type 2 diabetes proof-of-concept and fund a second menin asset for broader cardiometabolic use; oncology stays at the parent. Kura CEO Troy Wilson is executive chair; Rob Spencer is president and COO. Phase 1 is targeted by the end of 2027.  (Link)
  5. Implicity Raises $40 Million Growth Round Led by IRIS and Five Arrows IRIS and Rothschild & Co’s Five Arrows led a $40 million growth round in Implicity. The Cambridge and Paris company already covers more than 250 medical centers and monitors 120,000-plus patients a day across the United States, France and Germany. The platform is FDA-cleared AI sitting on connected pacemakers, defibrillators and implantable loop recorders; published real-world data cite a 26% mortality reduction and a 4% drop in hospitalizations versus conventional remote monitoring. Proceeds go to U.S. commercial hiring, U.S.-specific product work and further AI, including heart-failure prediction.  (Link)
  6. Epsilon Health Emerges from Stealth with $27.6 Million Led by AlleyCorp AlleyCorp led a $27.6 million stealth round in Epsilon Health; Uncork Capital, Renegade Partners, SemperVirens and Jack Altman joined. Epsilon is an AI-native radiology practice — physicians plus models — not a point-solution vendor selling into someone else’s group. It already serves more than 250,000 patients, reads 2,500-plus studies a day, and handles more than half the volume at one large outpatient imaging chain. Management says it is on track for about 1% of daily U.S. X-rays this year. Head of machine learning is ex-DeepMind; the CMO is former Envision Radiology CMO.  (Link)
  7. GenHealth.ai Raises $16.5 Million Series A Led by Flare Capital Partners Flare Capital Partners led a $16.5 million Series A in GenHealth.ai. Craft Ventures and Obvious Ventures re-upped; Eniac, InHealth Ventures, Epsilon Health Investors and ARTIS came in. Cumulative capital is about $30 million after a 2023 seed. The Boston company, spun out of 1upHealth, deploys agents inside existing EHRs and payer systems for intake, eligibility, prior authorization, billing, denials and appeals rather than selling another system of record. Management cites a 34% revenue lift and up to 80% admin-cost reduction; Guidehealth reports 4x productivity on intake and prior auth.  (Link)
  8. UrgentIQ Raises $15 Million Series A Led by Five Elms Capital Five Elms Capital, a vertical-software growth shop with more than $3 billion under management, led a $15 million Series A in UrgentIQ. The product is an AI-native EMR and operating system built for urgent care rather than a hospital or primary-care fork. Proceeds fund a native billing module, AI documentation and coding, live insurance verification and an AI checkout agent, plus commercial headcount. Founder Nat Gibbs is building against a market that still runs on hospital-grade EMRs never designed for high-throughput episodic visits. Earlier seed capital was not a named institutional growth round.  (Link)

CLICK HERE to sign up
for all news and updates

Spenser Lin No Comments

Healthcare News, Deals, and Investments Update May 11th, 2026

LECO_Weekly-Healthcare-News_5-11-2026Download
  1. Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease Angelini Pharma S.p.A., an international pharmaceutical company and part of Italy’s Angelini Industries Group, entered into a definitive agreement to acquire Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a Coral Gables, FL-based commercial-stage biopharmaceutical company focused on rare and difficult-to-treat diseases, in an all-cash transaction valued at approximately $4.1 billion or $31.50 per share. The deal, announced May 7, 2026, represents a premium to Catalyst’s recent trading prices and will expand Angelini Pharma’s U.S. market presence and rare-disease portfolio, particularly in brain health and neurological conditions. Closing is expected in the third quarter of 2026, subject to Catalyst stockholder approval, regulatory clearances, and other customary conditions. (Link)
  2. Roche Holding AG (SIX: RO, ROP; OTCQX: RHHBY), the Swiss pharmaceutical and diagnostics giant, entered into a definitive merger agreement to acquire PathAI, a Boston-based AI-powered digital pathology company, for USD 750 million upfront plus up to USD 300 million in milestone payments, valuing the deal at up to USD 1.05 billion. Roche (SIX: RO, ROP; OTCQX: RHHBY) has signed a definitive merger agreement to acquire Boston-based digital pathology firm PathAI. Under the terms of the agreement, Roche will pay a purchase price of USD 750 million upfront and additional milestone payments of up to USD 300 million, bringing total potential consideration to USD 1.05 billion. Roche has partnered with the company since 2021, expanding their agreement in 2024 to include the development of AI-enabled companion diagnostic algorithms. Roche Diagnostics will absorb PathAI as an operating unit after closing expected in H2 2026, pending regulatory clearance, accelerating Roche’s AI-powered diagnostics capabilities. (Link)
  3. Cross Country Healthcare, Inc. (NASD: CCRN), a Boca Raton-based technology-driven healthcare workforce solutions company, entered into a definitive agreement to be acquired by growth-oriented private equity firm Knox Lane in an all-cash transaction valued at approximately $437 million, or $13.25 per share. Cross Country Healthcare (NASDAQ: CCRN) has signed a definitive agreement to be taken private by Knox Lane, a growth-oriented investment firm, in an all-cash transaction valued at $437 million, or $13.25 per share. The price represents a premium of approximately 31% to CCRN’s closing price on May 6, 2026, and a 45% premium to its 90-day volume-weighted average trading price. Knox Lane is a private equity firm with $3.5 billion in assets under management. Upon completion, Cross Country Healthcare will become a privately held platform company in Knox Lane’s portfolio and will cease trading on Nasdaq, with closing expected in Q3 2026.  (Link)
  4. Sanford Health, a Sioux Falls, South Dakota-based nonprofit rural health system, and North Memorial Health, a Twin Cities-based Minnesota nonprofit health system, signed a definitive agreement to combine into a single nonprofit organization, supported by a planned $600 million investment. Sanford Health and North Memorial Health have signed a definitive agreement to combine into a single nonprofit health system. The transaction includes a $600 million investment in Twin Cities services. Sanford’s most recent annual revenue was nearly $11.7 billion in 2025, which reflects its merger with Marshfield Clinic Health System in Wisconsin. Sanford Health President and CEO Bill Gassen will continue to serve as president and chief executive officer of the combined organization. The partnership is expected to close sometime this year, subject to completion of regulatory processes and other customary closing conditions. (Link)
  5. The University of Pittsburgh Medical Center (UPMC), a Pittsburgh-headquartered nonprofit health care provider and insurer, and CommonSpirit Health, one of the nation’s largest nonprofit Catholic healthcare organizations, signed a definitive agreement transferring ownership of Steubenville, Ohio-based Trinity Health System to UPMC. UPMC and CommonSpirit Health have signed a definitive agreement transferring ownership of Trinity Health System to UPMC. The transfer includes Trinity West, Trinity East, Trinity St. Clairsville Neighborhood Hospital, Trinity Twin City Medical Center, and associated clinics, to UPMC. The transaction is expected to be completed in Fall 2026, pending regulatory review and customary closing conditions. The deal will allow UPMC to expand into the Midwest from its foothold in the mid-Atlantic. Financial terms were not disclosed. The deal marks UPMC’s first expansion into Ohio while supporting CommonSpirit’s multiyear asset-divestiture turnaround strategy. (Link)
  6. agilon health, inc. (NYSE: AGL), an Austin, TX-based value-based care platform partnering with primary care physicians on Medicare Advantage, saw its stock surge after delivering Q1 2026 revenue of $1.42 billion and GAAP EPS of $1.80, prompting upgrades from Deutsche Bank and Jefferies. agilon health (NYSE: AGL) shares surged sharply following a Q1 2026 earnings beat. Revenue came in at $1.42 billion versus analyst estimates of $1.38 billion, EPS (GAAP) of $1.80 crushed the consensus of $0.83, and Adjusted EBITDA of $53.84 million beat estimates of $36.15 million by nearly 49%. Deutsche Bank upgraded agilon health’s stock rating to Buy from Hold, raising its price target to $49.00, while Jefferies also upgraded the stock to Buy. For the full year, the company raised its 2026 Adjusted EBITDA guidance to $10–$40 million, with new CEO Tim O’Rourke commencing leadership. (Link)
  7. Addus Enters Indiana With HomeCourt Acquisition, Lines Up Second Deal Addus HomeCare Corporation (NASDAQ: ADUS), a Frisco, Texas-based provider of home and community-based personal care services, acquired HomeCourt Home Care, a Fort Wayne, Indiana-based non-medical home care agency. Addus HomeCare has entered the Indiana market through the acquisition of HomeCourt Home Care. The deal adds approximately $9.8 million in annualized revenue and expands Addus’ footprint into the Midwest with a strong regional provider of in-home personal care and supportive services for elderly and disabled clients. The transaction closed on May 1, 2026 and marks Addus’ continued geographic expansion strategy in the home-care sector. Financial terms were not disclosed. (Link)
  8. HealthVerity, Inc., a Philadelphia-based leader in privacy-protected real-world data exchange and patient identity solutions, entered into a definitive agreement to acquire Symphony Health Solutions Corporation, a commercial healthcare data and analytics business formerly part of ICON plc (NASDAQ: ICLR). HealthVerity has announced the acquisition of Symphony Health to combine its clinical data depth with Symphony’s commercial insights, creating a unified, AI-ready platform for life sciences, payers, and government entities. The transaction, announced on May 5, 2026, is expected to close in May 2026 subject to customary closing conditions. Financial terms were not disclosed. (Link)
  9. Elsevier completes acquisition of Mytonomy and introduces comprehensive end to end patient engagement solutions for healthcare providers. Elsevier, a global leader in scientific publishing and health information solutions (part of RELX plc), completed the acquisition of Mytonomy, Inc., a Washington, D.C.-based provider of cloud-based video patient engagement and education platforms for hospitals and health systems. Elsevier has completed the acquisition of Mytonomy to integrate its clinical content libraries with Mytonomy’s video-first patient engagement platform, creating end-to-end solutions that improve adherence, reduce readmissions, and support value-based care across the care continuum. The deal, closed on May 5, 2026, combines Elsevier’s trusted evidence-based content with Mytonomy’s HIPAA-compliant, personalized video and interactive tools already deployed at more than 300 U.S. healthcare organizations. Financial terms were not disclosed. (Link)
  10. CQ Medical, the Avondale, Pennsylvania-based global leader in radiotherapy positioning solutions formed in 2022 through the combination of CIVCO Radiotherapy and Qfix, acquired .decimal, a Sanford, Florida-based precision manufacturer of patient-specific radiotherapy beam-shaping devices. CQ Medical has acquired .decimal to expand its patient-specific cancer treatment portfolio. CQ Medical was formed in 2022 through the combination of CIVCO Radiotherapy and Qfix, bringing together decades of expertise in essential radiation therapy positioning and immobilization solutions. Serving the radiotherapy clinical community for more than 40 years, .decimal is a trusted partner known for its rapid production of customized, patient-specific devices—typically manufactured and shipped within 1–2 days of order receipt. To date, the company has delivered over 500,000 patient-specific treatment devices, and actively serves more than 900 cancer centers across the United States. Financial terms were not disclosed. (Link)
  11. Med Tech Solutions (MTS), a Valencia, California-based managed healthcare IT services provider and portfolio company of Silversmith Capital Partners, acquired Avarion (formerly Huntzinger Management Group), a two-time Best in KLAS healthcare IT advisory firm, to span the full care continuum. Silversmith Capital Partners-backed Med Tech Solutions has acquired Avarion to strengthen its managed services platform. Med Tech Solutions, a provider of managed healthcare IT services and a portfolio company of Silversmith Capital Partners, acquired Avarion, a healthcare IT advisory firm serving hospitals, health systems and care networks. The combination unites MTS’ EHR managed services, application support, and technology infrastructure expertise with Avarion’s deep experience in healthcare IT advisory, consulting, and leadership services. Robert Kitts, Avarion’s CEO and founding partner, will report to Mona Abutaleb, CEO of MTS, and lead the company’s strategic advisory and staffing services. Financial terms were not disclosed. (Link)
  12. TimelyCare, a Fort Worth, TX-based virtual care provider for higher education serving nearly 500 campuses nationwide, acquired Alongside, a clinician-designed AI coaching platform trusted by more than 200 schools, to expand its student support model with continuous early-intervention AI coaching. TimelyCare has acquired Alongside, a clinician-designed AI coaching platform for students. Alongside combines evidence-based skill-building with proprietary safety models that detect risk and connect students to additional support when needed. Trusted by nearly 500 campuses across the U.S., TimelyCare combines URAC-accredited clinical standards with a measurement-based approach, while Alongside is trusted by more than 200 schools nationwide. The acquisition expands TimelyCare’s approach beyond traditional points of clinical need, positioning the company to engage a broader student population earlier and more consistently across the care continuum. Financial terms were not disclosed. (Link)
  13. Xpress Wellness, a Goldman Sachs-backed Oklahoma City-based provider of urgent care, virtual primary care, occupational medicine, behavioral health and post-acute services, acquired Midwest Counseling Services, a Wichita, Kansas-based mental health clinic founded in 2022 serving older adults in senior communities. Goldman Sachs-backed Xpress Wellness has acquired Wichita-based Midwest Counseling Services. Founded in 2022, Midwest Counseling Services provides mental health services to older adults living in senior communities through approaches including talk therapy and individual counseling. Xpress Wellness is an Oklahoma City-based provider of urgent care, virtual primary care, occupational medicine, behavioral health and post-acute services across rural and suburban communities. Lisa Harrison, founder of Midwest Counseling Services, now serves as Xpress Wellness’ Director of Operations of Post-Acute overseeing the Kansas market, with the deal expanding the acquirer’s behavioral health footprint in Kansas and adjacent states. (Link)
  14. Pediatrica Health Group, a Miami-based multi-site pediatric primary care platform backed by M33 Growth, acquired the long-established Westchester, Miami-Dade pediatric practice of Dr. Juan Ruiz-Unger to expand equitable access to care amid rising regional population growth. Pediatrica Health Group, backed by Boston-based venture and growth-stage investor M33 Growth, has acquired an additional pediatric practice in the Westchester neighborhood of Miami-Dade County. For over 40 years, Dr. Juan Ruiz-Unger has delivered compassionate, evidence-based care to Westchester families. Roberto Palenzuela, Chief Executive Officer of Pediatrica Health Group, said the acquisition aligns with the company’s goal of supporting physicians who want to expand access while maintaining continuity of care within their communities. Financial terms were not disclosed. The deal continues Pediatrica’s multi-site pediatric primary care roll-up strategy across South Florida. (Link)
  15. SpinLife, a Columbus, Ohio-based omni-channel mobility and home accessibility retailer owned by Brentwood, Tennessee-based Complex Rehab Technology leader Numotion, acquired Triton Medical and opened a new SpinLife retail store in Lady Lake, Florida, expanding its Central Florida footprint. Numotion-owned SpinLife has acquired Triton Medical and launched a new Central Florida retail location. SpinLife, owned by Numotion, said in a May 5 announcement that the acquisition was completed on April 22. The retail location is now operating as SpinLife — Lady Lake and strengthens the company’s presence in central Florida and enhancing service to the growing Lady Lake and The Villages communities. Matt Chesshire, Triton Medical’s founder, will remain at the Lady Lake store as general manager. Numotion acquired SpinLife in 2021. Financial terms were not disclosed. (Link)
  16. Care Advantage, Inc., a Mid-Atlantic-based privately held home care provider, announced the acquisition of First Priority Home Care, a Columbia, South Carolina-based non-medical home care agency, advancing its targeted expansion strategy across the Mid-Atlantic and Southeast. Care Advantage, Inc. has acquired Columbia, South Carolina-based First Priority Home Care. Care Advantage, one of the Mid-Atlantic’s largest privately held home care providers, today announced the acquisition of First Priority Home Care, based in Columbia, South Carolina. This latest transaction marks another step in Care Advantage’s continued expansion into the southern United States. First Priority Home Care is a non-medical home care agency based in Columbia, South Carolina, providing in-home support services to seniors and adults who need assistance. Financial terms of the deal were not disclosed. (Link)
  17. Standard Dental Labs Inc., (OTCQB:TUTH) an Orlando-based publicly traded dental laboratory consolidator, completed the acquisition of BRLIT Dental Laboratory, a Sarasota, Florida-based dental lab founded in 1977, adding approximately $886,000 in annual revenue. Standard Dental Labs Inc. (OTCQB: TUTH) has completed the acquisition of BRLIT Dental Laboratory in Sarasota, Florida. The transaction adds approximately $886,000 in annual revenue to Standard Dental Labs’ existing revenue base of approximately $236,000, bringing the company’s total annualized revenue to more than $1.1 million. The company holds a market capitalization of $6.54 million. BRLIT Dental Laboratory, founded in 1977, has served dentists throughout Florida for nearly five decades, and the acquisition expands the buyer’s footprint along Florida’s Gulf Coast. The company intends to continue pursuing strategic acquisitions in Florida’s dental laboratory industry. (Link)
  18. TopGum Industries Ltd. (TASE: TPGM), an Israel-based global leader in gummy-format dietary supplements, completed the acquisition of the U.S. gummy manufacturing operations of P&L Developments LLC, a Westbury, New York-based pharmaceutical and consumer healthcare CDMO, in a transaction valued at up to USD 35 million. TopGum Industries Ltd. (TASE: TPGM) has completed its acquisition of P&L Developments’ U.S. gummy manufacturing operations. The consideration, funded by TopGum’s existing resources, comprises US$10 million in cash at closing, 1,893,060 shares valued at approximately US$8 million at closing (based on a price of NIS 13 per share), and up to 4,022,751 additional shares (valued at up to US$17 million) as contingent consideration, payable upon achievement of agreed commercial and regulatory milestones.  (Link)
  19. Arete Health Announces Acquisitions of Virginia Rehabilitation & Wellness and Summerville Physical Therapy & Balance for Adults Arete Health, a physician-led multi-specialty practice management platform, acquired Virginia Rehabilitation & Wellness and Summerville Physical Therapy & Balance for Adults, two established physical therapy practices in Virginia. Arete Health has completed the acquisition of two Virginia-based physical therapy practices—Virginia Rehabilitation & Wellness and Summerville Physical Therapy & Balance for Adults—on May 5, 2026. The deals strengthen Arete’s outpatient rehabilitation footprint in the Mid-Atlantic and add specialized orthopedic, sports medicine, and balance therapy services. The combined practices serve several hundred patients weekly across multiple locations. Financial terms were not disclosed. (Link)

Venture Deals and Other

  1. Basata, a Phoenix-based AI company building the operational layer for U.S. healthcare, raised a $21 million Series A led by Basis Set Ventures with participation from Cowboy Ventures, PHX Ventures, Zenda Capital, and Victoria Treyger, bringing total funding to $24.5 million. Basata has closed a $21 million Series A funding round to scale its AI-driven healthcare administrative automation platform. The Series A was led by Basis Set Ventures, with participation from Cowboy Ventures, PHX Ventures, Zenda Capital, and Victoria Treyger. The round brings total funding to $24.5 million. Basis Set Ventures’ Lan Xuezhao led the round, joined by Cowboy Ventures’ Aileen Lee, PHX Ventures, Zenda Capital, and Victoria Treyger. The company has served more than 500,000 patients to date, including 100,000 patients during the past month alone, while working with specialty groups across cardiology, urology, gastroenterology, and ophthalmology. (Link)
  2. Dandelion Health, a New York-based clinical intelligence platform serving life sciences, raised a $14 million Series A led by Healthier Capital with participation from Colle Capital and existing investors Primary Venture Partners, Moxxie Ventures, and Convergent Ventures, to scale its multimodal clinical AI infrastructure. Dandelion Health has secured $14 million in Series A funding. Healthier Capital led the round, with participation from Colle Capital and existing investors Moxxie Ventures, Convergent Ventures and Primary Venture Partners. Built on a network spanning 73 hospitals and more than 15 million patients, Dandelion is unique in its ability to combine structured data — electronic medical records and claims — with unstructured clinical text and raw biological signals including ECG waveforms, echocardiogram videos, radiology imaging, pulmonary function tests, and ultrasound. The Series A financing will be used to expand Dandelion’s pharmaceutical partnerships, scale the company’s data and engineering infrastructure, and grow commercial and scientific teams. (Link)
  3. Enzo Health, a Lehi, Utah-based AI-driven platform for home health and post-acute care launched in 2024, raised a $20 million Series A led by global venture capital firm N47 with participation from existing investors Gradient (a Google-affiliated investment firm), Tandem Ventures, and Rigby Watts, bringing total funding to $26 million. Enzo Health has raised a $20 million Series A funding round. The round was led by N47, bringing the company’s total funding to $26M. Existing investors Gradient, Tandem Ventures, and Rigby Watts also participated. Existing investors Gradient (Palo Alto, a Google-affiliated investment firm), Tandem Ventures (Draper, UT), and Rigby Watts (Millcreek, UT) also participated. Launched in 2024, Enzo Health has grown revenue by more than 40X in twelve months and is now used by organizations that support over 500,000 patients annually. The funds will accelerate expansion into skilled nursing and hospice sectors. (Link)
  4. Travv, a Stillwater, Oklahoma-based AI-native diagnostic platform for veterinary medicine led by founder and CEO Derick Whitley, DVM, DACVP, closed a $1.6 million seed funding round led by Digitalis Ventures with participation from AniVC, to advance its cloud-based veterinary diagnostic platform. Travv has closed a $1.6 million seed funding round. Travv, a Stillwater, OK-based provider of an AI-native diagnostic platform for veterinary medicine, closed a $1.6m seed funding round. The round was led by Digitalis Ventures, with participation from AniVC. The funding will support continued development of Travv’s AI-native diagnostic platform for veterinary medicine, including product expansion, hospital onboarding, commercial growth, and key integrations. Digitalis Ventures backs founders solving critical problems in health. The firm invests in early-stage companies across life sciences, health technology & services, and animal health, while AniVC focuses on early-stage pet companies. (Link)
Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Mar 23rd, 2026

LECO_Weekly-Healthcare-News_3-23-2026Download
  1. GE HealthCare (NASD: GEHC) Completes $2.3B Acquisition of Intelerad to Bolster Cloud-First Imaging Solutions GE HealthCare (NASDAQ: GEHC) has finalized its acquisition of Intelerad Medical Systems, a leading provider of enterprise imaging software. This strategic move is designed to accelerate GE HealthCare’s transition toward cloud-based enterprise solutions and “precision care.” By integrating Intelerad’s informatics platform, GE HealthCare aims to improve clinician workflows and data accessibility across hospital systems. The acquisition enhances the company’s digital health portfolio, focusing on scalable, interoperable imaging tools that reduce administrative burdens. This deal reflects the broader industry trend of medical technology giants acquiring software firms to dominate the healthcare data infrastructure market. (Link)
  2. Movano (NASD: MOVE) Completes All-Stock Merger with Corvex (NASD: CVEX) and Rebrands Movano Health (NASDAQ: MOVE) and Corvex have completed a strategic merger, creating a unified entity focused on AI-driven cloud infrastructure for healthcare. Movano, known for its wearable medical technology and the Evie Ring, will leverage Corvex’s cloud capabilities to enhance its data analytics and patient monitoring services. The merger aims to create a “cloud infrastructure powerhouse” capable of processing large-scale health data for clinical and consumer applications. This transaction reflects the merging of hardware and software capabilities in the wearable tech space to provide more comprehensive, actionable health insights through artificial intelligence. (Link)
  3. Knowtion Health Acquires Revly to Enhance RCM and AI-Driven Denial Management Management via its financial sponsors Arsenal Capital Partners, Sunstone Partners and Ardan Equity Knowtion Health, a leader in revenue cycle management (RCM) and claim denial resolution, has acquired Revly, an AI-powered billing technology company. Knowtion Health is a portfolio company of Sunstone Partners. This acquisition integrates Revly’s advanced automation into Knowtion’s existing platforms to help hospitals and health systems recover unpaid claims more efficiently. By combining human expertise with Revly’s AI, Knowtion aims to reduce the rising rate of insurance denials. This deal underscores the high demand for AI-driven solutions in the administrative healthcare space to combat labor shortages and complex payer requirements. (Link)
  4. Prestige Consumer Healthcare (NYSE: PBH) to Acquire Breathe Right from Foundation Consumer Healthcare Prestige Consumer Healthcare Inc. (NYSE: PBH) has signed a definitive agreement to acquire the Breathe Right nasal strip brand from Foundation Consumer Healthcare. This acquisition strengthens Prestige’s portfolio of leading over-the-counter consumer brands, specifically within the respiratory care segment. Breathe Right is the global leader in the nasal strip category, and this move is expected to be immediately accretive to Prestige’s earnings and free cash flow. The deal highlights Prestige’s ongoing strategy of acquiring established, high-growth consumer health brands to leverage its existing retail distribution network and marketing infrastructure. (Link)
  5. Pacific Avenue Capital Partners Completes Acquisition of Care.com from IAC (NASD: IAC) An affiliate of Pacific Avenue Capital Partners has completed the acquisition of Care.com from IAC (NASDAQ: IAC). Care.com is the world’s leading platform for finding and managing high-quality family care, including childcare, senior care, and specialized medical care. Under the new ownership of Pacific Avenue, the company plans to invest in product innovation and expand its enterprise offerings for employers. This private equity buyout signifies a shift for Care.com as it moves away from a conglomerate structure to focus on independent growth in the rapidly expanding digital caregiving marketplace. (Link)
  6. Aria Care Partners Acquires Coronado Dental to Expand On-Site Clinical Services in Arizona via its financial sponsor Serent Capital Aria Care Partners, a leading provider of onsite ancillary medical services for skilled nursing facilities, has acquired Coronado Dental. This acquisition marks Aria’s entry into the Arizona market. Aria Care Partners, which is backed by private equity investment, focuses on delivering dental, vision, hearing, and podiatry services directly to residents in long-term care facilities. By acquiring Coronado Dental, Aria expands its footprint and reinforces its position as a dominant player in the specialized geriatric clinical services sector. The deal highlights the consolidation of fragmented ancillary care providers under larger, PE-backed management platforms. (Link)
  7. Blackstone-Backed (NYSE: BX) Chartis Acquires Health Tech Firm Leap AI The Chartis Group, a healthcare advisory and analytics firm backed by Blackstone (NYSE: BX), has acquired Leap AI. Leap AI specializes in healthcare-specific artificial intelligence automation, focusing on streamlining clinical and administrative workflows. This acquisition allows Chartis to integrate advanced AI capabilities into its consulting services, helping hospital systems improve operational efficiency. For Blackstone, this move represents a continued investment in “applied AI” within the healthcare sector, moving beyond general software into tools that solve specific provider pain points. The deal highlights the aggressive expansion of tech-enabled consulting platforms. (Link)
  8. WELL Health (TSX: WELL) Subsidiary WELLSTAR Acquires Two Billing Platforms to Expand National Footprint WELLSTAR, a subsidiary of WELL Health Technologies Corp. (TSX: WELL), has completed the acquisition of two strategic billing and back-office service providers. These acquisitions expand WELL’s national billing platform, which now serves medical professionals across six Canadian provinces. WELL Health continues its “buy-and-build” strategy, acquiring fragmented healthcare IT and billing services to create a unified, tech-enabled provider network. By scaling its billing division, WELL increases its recurring revenue and strengthens its position as the largest owner-operator of outpatient clinics in Canada, providing essential administrative infrastructure to thousands of physicians. (Link)
  9. James River Home Health Acquires Golden Rule Hospice to Expand End-of-Life Care Services James River Home Health and Hospice has completed the acquisition of Golden Rule Hospice. This strategic move expands James River’s service area and strengthens its specialized hospice care offerings. The acquisition is part of James River’s effort to build a comprehensive home-based care network that covers both skilled home health and end-of-life services. As the demand for aging-in-place solutions grows, regional providers like James River are increasingly acquiring boutique hospice agencies to achieve better economies of scale and improve clinical outcomes through standardized care models. (Link)
  10. Loma Linda University Health and Kara Health Form Joint Venture for New Hospice Agency Loma Linda University Health (LLUH) has partnered with Kara Health to launch a joint venture called Loma Linda University Hospice. Kara Health is a tech-enabled home care and hospice provider. This partnership combines LLUH’s clinical excellence with Kara Health’s proprietary technology platform to provide high-quality, data-driven end-of-life care. The joint venture aims to improve patient transitions from the hospital to the home and enhance the palliative care experience through remote monitoring and streamlined communication. This model illustrates the growing trend of health systems partnering with startups to modernize home health. (Link)
  11. Palladium Equity Partners Acquires Majority Stake in DME Express from Waypoint Capital Palladium Equity Partners, LLC has announced its acquisition of a majority interest in DME Express, a leading provider of medical equipment services to the hospice industry. The stake was acquired from Waypoint Capital Partners. DME Express specializes in high-touch delivery and management of durable medical equipment (DME), primarily serving hospice and post-acute care facilities. Palladium’s investment is aimed at accelerating the company’s geographic expansion and enhancing its service capabilities. This transaction underscores the increasing interest from private equity in specialized logistics and equipment providers within the value-based care and end-of-life care sectors. (Link)
  12. SportsMed Physical Therapy Expands to 54 Clinics with New Connecticut Locations SportsMed Physical Therapy, a leading provider of physical therapy, chiropractic, and acupuncture services, has opened two new clinics in Connecticut. These openings bring the company’s total to 54 locations across New Jersey and Connecticut. SportsMed, which has received investment from private equity firms, continues to pursue a rapid “de novo” growth strategy alongside strategic acquisitions. The company focuses on a multidisciplinary approach to musculoskeletal health. This expansion reflects the high investor interest in the physical therapy sector due to its predictable revenue streams and the increasing demand for non-invasive pain management solutions. (Link)
  13. Allina Health to join Sutter Health in $26B proposed transaction in Strategic Realignment Allina Health has released a strategic announcement regarding its long-term operational and investment plan for its Minnesota-based health system. The plan includes a focus on clinical service realignment and infrastructure investment to support high-growth areas like cardiovascular and oncology care. While not a sale of the company, the announcement details strategic capital allocations aimed at improving financial stability and patient access. This news is critical for investors monitoring the financial health of non-profit systems and their shift toward outpatient-focused care models in a challenging economic environment for hospitals. (Link)
  14. Providence Explores Strategic Options Including Sale of Providence Health Plan Providence, one of the largest non-profit health systems in the U.S., has announced it is exploring strategic options for the sale of its Providence Health Plan (PHP) division. PHP is a regional health insurer serving hundreds of thousands of members in Oregon and Washington. This potential divestiture is part of Providence’s effort to shore up its balance sheet and focus resources on its core hospital operations. A sale would likely attract interest from major national insurers or private equity groups seeking a foothold in the Pacific Northwest insurance market. (Link)
  15. Valir Health Expands Senior Care Presence in Oklahoma City Valir Health has announced the acquisition of a prominent senior care facility in Oklahoma City, continuing its expansion in the post-acute care and geriatric services sector. Valir Health provides a range of services including inpatient rehabilitation, hospice care, and billing solutions. This acquisition is part of Valir’s broader strategy to consolidate senior living and rehabilitation services within the Oklahoma region. By integrating this new facility, Valir aims to improve care coordination for the elderly population. The deal reflects a regional trend of mid-sized healthcare companies expanding their physical footprint to meet growing geriatric demand. (Link)

Venture Deals

  1. Unnatural Products Raises $45 Million Series B Led by Nextech Invest and Frazier Life Sciences with participation from Northpond Ventures, Cool Springs Financial, and others to Advance Peptide Therapeutics Unnatural Products (UNP), a biotech firm specializing in macrocyclic peptide therapeutics, has secured $45 million in Series B financing. The round was led by Nextech Invest and Frazier Life Sciences, with participation from Northpond Ventures, Cool Springs Financial, and others. The company uses a platform that combines AI and medicinal chemistry to create “unnatural” macrocycles that can hit difficult-to-target intracellular proteins. The capital will be used to advance its lead oncology programs into the clinic and expand its platform capabilities. This funding highlights continued investor confidence in AI-driven drug discovery platforms targeting previously “undruggable” pathways. (Link)
  2. Conduit Health Raises $17 Million Series A Led by Drive Capital to Expand AI-Powered DME Access Conduit Health has raised $17 million in Series A funding led by Drive Capital. Conduit Health operates an AI-powered platform designed to streamline access to Durable Medical Equipment (DME). The platform connects healthcare providers, payers, and suppliers to automate the ordering and fulfillment process, which is traditionally fragmented and manual. The investment will be used to scale the company’s technology and expand its market presence. This deal underscores the venture capital interest in solving administrative bottlenecks within the home health and medical supply chain using modern software-as-a-service (SaaS) models. (Link)
  3. Verily Secures $300 Million Investment Led by Alphabet (NASDAQ: GOOGL) to Advance Precision Health AI Verily, the life sciences subsidiary of Alphabet (NASDAQ: GOOGL), has secured a $300 million investment to accelerate its precision health AI strategy. This funding round, supported by parent company Alphabet and other institutional investors, will focus on scaling Verily’s data-driven clinical research and care management solutions. The company aims to use the capital to further integrate artificial intelligence into its “Lightship” clinical trial platform and its chronic condition management tools. This massive investment signals Google’s long-term commitment to becoming a dominant player in the convergence of big data, AI, and clinical healthcare. (Link)
  4. Turquoise Health Raises $40 Million Series B Led by Adams Street Partners with participation from Andreessen Horowitz (a16z) and BoxGroup to Power Healthcare Price Transparency Turquoise Health, a healthcare pricing platform, has raised $40 million in Series B funding led by Adams Street Partners, with participation from Andreessen Horowitz (a16z) and BoxGroup. Turquoise Health provides software that enables hospitals and payers to comply with price transparency regulations and manage data-driven contracts. The company intends to use the funds to expand its “ClearContract” platform, which automates the negotiation and management of payer-provider contracts. This investment highlights the growing importance of data transparency tools as healthcare shifts toward value-based care and more complex reimbursement models. (Link)
  5. Condor Software Raises $24 Million Series A Led by Bessemer Venture Partners with participation from Casdin Capital and existing investors for Clinical Trial Finance Management Condor Software has secured $24 million in Series A funding led by Bessemer Venture Partners, with participation from Casdin Capital and existing investors. Condor Software provides a specialized financial management platform for biotech companies to track and manage the complex costs associated with clinical trials. The company aims to replace manual spreadsheets with automated workflows that integrate with clinical and financial data. The new capital will be used to scale its engineering team and accelerate product development, reflecting the niche but high-value demand for fintech solutions tailored specifically to the life sciences industry. (Link)
  6. RAAPID Secures Series A Extension Led by Celesta Capital to Scale Neuro-Symbolic AI for Medical Coding RAAPID has secured a Series A extension funding round led by Celesta Capital to scale its “Neuro-Symbolic” AI-powered medical coding and risk adjustment platform. The company’s technology helps healthcare providers and insurers automate the complex process of clinical documentation and coding, ensuring accurate reimbursement. By combining deep learning with symbolic AI, RAAPID aims to provide higher accuracy and transparency than traditional LLM models. The funding will support geographic expansion and further R&D. This deal illustrates the shift toward specialized, high-accuracy AI tools for administrative healthcare tasks where error margins are critical. (Link)
  7. Health Universe Raises $6 Million Seed Round Led by Eniac Ventures for AI Agents in Medical Workflows Health Universe, a platform for developing and deploying AI “agents” for medical workflows, has raised $6 million in a seed funding round led by Eniac Ventures. The platform allows developers and clinicians to collaborate on AI models that automate specific clinical tasks, such as surgery scheduling or pathology reporting. Health Universe provides the infrastructure for hosting and running these models securely in a compliant environment. This investment highlights the emerging “AI-as-a-Service” model within healthcare, where platforms provide the tools for specialized, agentic AI to be integrated into daily hospital operations. (Link)